{
    "clinical_study": {
        "@rank": "134601", 
        "arm_group": [
            {
                "arm_group_label": "BDP 80 mcg BAI", 
                "arm_group_type": "Experimental", 
                "description": "Beclomethasone dipropionate (BDP) via breath-actuated inhaler (BAI) twice daily for a total of 80 mcg/day."
            }, 
            {
                "arm_group_label": "BDP 160 mcg BAI", 
                "arm_group_type": "Experimental", 
                "description": "Beclomethasone dipropionate (BDP) via breath-actuated inhaler (BAI) twice daily for a total of 160 mcg/day."
            }, 
            {
                "arm_group_label": "Placebo BAI", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo breath-actuated inhaler (BAI) twice daily."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a randomized, double-blind, placebo-controlled parallel-group study. Participants\n      will be randomly assigned to receive treatment with beclomethasone dipropionate at a dosage\n      of 80 or 160 mcg/day delivered via a Breath-Actuated Inhaler (BAI); or a matching BAI\n      placebo, in a 1:1:1 ratio after a 14- to 21-day run-in period. Participants and\n      investigators will remain blinded to randomized treatment assignment during the study.\n\n      The study consists of 3 periods:\n\n        -  run-in period: Screening visit (SV) to randomization visit (RV), 14-21 days (2-3 weeks)\n           prior to study start\n\n        -  double-blind treatment period: RV through the final treatment visit, 85\u00b13 days or 12\n           weeks after study start.\n\n        -  follow-up period: a follow-up visit/telephone call, 7\u00b13 days after the treatment period\n           ends."
        }, 
        "brief_title": "A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Persistent Asthma", 
        "condition_browse": {
            "mesh_term": "Asthma"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Severity of Disease: The patient has persistent asthma, with an forced expiratory\n             volume in 1 second (FEV1) 40%-85% of the value predicted for age, height, sex, and\n             race as per the National Health and Nutrition Examination Survey (NHANES III)\n             reference values at screening visit (SV) (Hankinson et al 1999).\n\n          -  Current asthma therapy: The patient is currently being treated with 1 of the\n             following:\n\n             1) inhaled corticosteroids (ICSs) at a stable daily dose of less than or equal to 220\n             mcg/day fluticasone propionate via metered dose inhaler (MDI) or equivalent for a\n             minimum of 4 weeks (28 days) before screening visit, or 2) a stable daily dosage of\n             non-corticosteroid therapy, including leukotriene modifiers, theophylline, chromones,\n             or short-acting  beta-2 agonists (SABAs) alone or in combination for a minimum of 4\n             weeks (28 days) before screening visit (SV).\n\n          -  Reversibility of disease: The patient has demonstrated at least 15% and at least 200\n             mL increase from baseline FEV1 (patients age 18 and older) within 30 minutes after\n             2-4 inhalations of albuterol/salbutamol hydrofluoroalkane (HFA) MDI (90 mcg\n             ex-actuator) or equivalent at SV or on retesting.  - Other criteria apply, please\n             contact the investigator for more information\n\n        Exclusion Criteria:\n\n          -  The patient has a history of life-threatening asthma, defined for this protocol as an\n             asthma episode that required intubation and/or was associated with hypercapnea,\n             respiratory arrest, or hypoxic seizures.\n\n          -  The patient is a pregnant or lactating female or plans to become pregnant.\n\n          -  The patient has a known hypersensitivity to any corticosteroid or any of the\n             excipients in the study drug or rescue medication formulation.\n\n          -  The patient currently smokes or has a smoking history of 10 pack-years or more (a\n             pack-year is defined as smoking 1 pack of cigarettes/day for 1 year). The patient may\n             not have used tobacco products within the past year.\n\n          -  The patient has had an asthma exacerbation requiring oral corticosteroids within 1\n             month before SV, or has had any hospitalization for asthma within 2 months before SV.\n\n          -  The patient has historical or current evidence of a clinically significant disease.\n             Significant disease is defined as any disease that in the medical judgment of the\n             investigator would put the safety of the patient at risk through participation or\n             that could affect the efficacy or safety analysis if the disease/condition worsened\n             during the study.\n\n          -  Other criteria apply, please contact the investigator for more information"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": {
            "#text": "270", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02040779", 
            "org_study_id": "BDB-AS-304"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "BDP 80 mcg BAI", 
                    "BDP 160 mcg BAI"
                ], 
                "description": "Participants are instructed to rinse their mouth and expectorate (not swallow) after study drug administration.", 
                "intervention_name": "Beclomethasone dipropionate breath-actuated inhaler", 
                "intervention_type": "Drug", 
                "other_name": "BDP"
            }, 
            {
                "arm_group_label": "Placebo BAI", 
                "description": "Placebo breath-actuated inhaler (BAI) 1 inhalation twice daily for a total daily dose of 0 mcg.", 
                "intervention_name": "Placebo breath-actuated inhaler", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "BDP 80 mcg BAI", 
                    "BDP 160 mcg BAI", 
                    "Placebo BAI"
                ], 
                "description": "Rescue medication (albuterol/salbutamol hydrofluoroalkane (HFA) MDI [90 mcg ex-actuator] or equivalent) for use on an as-needed basis for the immediate relief of asthma symptoms throughout the treatment period", 
                "intervention_name": "albuterol/salbutamol", 
                "intervention_type": "Drug", 
                "other_name": "bronchodilators"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Albuterol", 
                "Bronchodilator Agents", 
                "Beclomethasone"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "asthma", 
            "breath-actuated inhaler", 
            "beclomethasone"
        ], 
        "lastchanged_date": "May 20, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Mission Viejo", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Teva Investigational Site 10944"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orange", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Teva Investigational Site 10946"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rolling Hills Estates", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Teva Investigational Site 10963"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Teva Investigational Site 10973"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Teva Investigational Site 10960"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Jose", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Teva Investigational Site 10975"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Centennial", 
                        "country": "United States", 
                        "state": "Colorado"
                    }, 
                    "name": "Teva Investigational Site 10948"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Colorado Springs", 
                        "country": "United States", 
                        "state": "Colorado"
                    }, 
                    "name": "Teva Investigational Site 10957"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado"
                    }, 
                    "name": "Teva Investigational Site 10958"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tallahassee", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Teva Investigational Site 10962"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana"
                    }, 
                    "name": "Teva Investigational Site 10947"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iowa City", 
                        "country": "United States", 
                        "state": "Iowa"
                    }, 
                    "name": "Teva Investigational Site 10943"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland"
                    }, 
                    "name": "Teva Investigational Site 10954"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "North Dartmouth", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }, 
                    "name": "Teva Investigational Site 10955"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }, 
                    "name": "Teva Investigational Site 10941"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbia", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "Teva Investigational Site 10970"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rolla", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "Teva Investigational Site 10968"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bozeman", 
                        "country": "United States", 
                        "state": "Montana"
                    }, 
                    "name": "Teva Investigational Site 10972"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bellevue", 
                        "country": "United States", 
                        "state": "Nebraska"
                    }, 
                    "name": "Teva Investigational Site 10942"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Skillman", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }, 
                    "name": "Teva Investigational Site 10959"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "Teva Investigational Site 10945"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sylvania", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "Teva Investigational Site 10974"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tulsa", 
                        "country": "United States", 
                        "state": "Oklahoma"
                    }, 
                    "name": "Teva Investigational Site 10951"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lake Oswego", 
                        "country": "United States", 
                        "state": "Oregon"
                    }, 
                    "name": "Teva Investigational Site 10940"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Medford", 
                        "country": "United States", 
                        "state": "Oregon"
                    }, 
                    "name": "Teva Investigational Site 10952"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon"
                    }, 
                    "name": "Teva Investigational Site 10956"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Teva Investigational Site 10969"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Teva Investigational Site 10949"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "El Paso", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Teva Investigational Site 10953"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Braunfels", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Teva Investigational Site 10950"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Teva Investigational Site 10961"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington"
                    }, 
                    "name": "Teva Investigational Site 10967"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greenfield", 
                        "country": "United States", 
                        "state": "Wisconsin"
                    }, 
                    "name": "Teva Investigational Site 10964"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma", 
        "overall_contact": {
            "last_name": "US Teva Medical Information", 
            "phone": "800-896-5855"
        }, 
        "overall_official": {
            "affiliation": "TEVA", 
            "last_name": "Medical Director, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measurements taken pre-dose and pre-rescue bronchodilator", 
            "measure": "Change from Baseline in Trough Morning Forced Expiratory Volume in 1 Second (FEV1) over the 12-week Treatment Period", 
            "safety_issue": "No", 
            "time_frame": "Day 1 (baseline), up to 12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02040779"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from Baseline in Weekly Average of Daily Trough Morning Peak Expiratory Flow (PEF) over the 12-week Treatment Period", 
                "safety_issue": "No", 
                "time_frame": "Day 1 (baseline), up to 12 weeks"
            }, 
            {
                "measure": "Change from Baseline in Weekly Average of Daily Evening Peak Expiratory Flow (PEF) over the 12-week Treatment Period", 
                "safety_issue": "No", 
                "time_frame": "Day 1 (baseline), up to 12 weeks"
            }, 
            {
                "measure": "Time to Participant Withdrawal Due to Meeting Stopping Criteria for Worsening Asthma during the 12-week Treatment Period", 
                "safety_issue": "No", 
                "time_frame": "up to 12 weeks"
            }, 
            {
                "measure": "Change from Baseline in the Weekly Average of Total Daily (24-hour) Use of Albuterol/Salbutamol Inhalation Aerosol (Number of Inhalations) over weeks 1-12", 
                "safety_issue": "No", 
                "time_frame": "Day 1 (baseline), weeks 1-12"
            }, 
            {
                "description": "The total daily asthma symptom score is the average of the daytime and nighttime scores.", 
                "measure": "Change from Baseline in the Weekly Average of Total Daily Asthma Symptom Score over Weeks 1-12", 
                "safety_issue": "No", 
                "time_frame": "Day 1 (baseline), weeks 1-12"
            }
        ], 
        "source": "Teva Pharmaceutical Industries", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Teva Branded Pharmaceutical Products, R&D Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}